Cytosorbents (CTSO) Gross Profit Growth (5y) (2016 - 2026)
Cytosorbents (CTSO) Gross Profit Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | Cytosorbents | 22.57 Mn | 17.77 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.82% |
| Dec 31, 2025 | -6.32% |
| Sep 30, 2025 | -2.73% |
| Jun 30, 2025 | 0.81% |
| Mar 31, 2025 | -0.37% |
| Dec 31, 2024 | 3.23% |
| Sep 30, 2024 | 3.63% |
| Jun 30, 2024 | 8.14% |
| Mar 31, 2024 | 14.76% |
| Dec 31, 2023 | 5.85% |
| Sep 30, 2023 | 8.73% |
| Jun 30, 2023 | 8.68% |
| Mar 31, 2023 | 10.20% |
| Dec 31, 2022 | 11.23% |
| Sep 30, 2022 | 9.41% |
| Jun 30, 2022 | 18.86% |
| Mar 31, 2022 | 28.10% |
| Dec 31, 2021 | 33.79% |
| Sep 30, 2021 | 38.19% |
| Jun 30, 2021 | 47.17% |